Do not display

Threat Of Obamacare Repeal Leaves Community Health Centers In Limbo

KFF Health News Original

These clinics have long provided health care to low-income patients and enjoyed expansion under the Affordable Care Act. With repeal looming, the centers’ doctors worry about what’s next.

Drugmaker Kaleo Raises Price Of Lifesaving Drug By Thousands

KFF Health News Original

Kaiser Health News reporter Shefali Luthra discusses the controversy surrounding Kaleo, a company that makes a life-saving auto-injector for opioid drug overdoses on Weekend Edition.

Republicans Standing Behind Price

KFF Health News Original

KHN’s Julie Rovner is interviewed on WBUR’s “Here and Now” about the Senate Finance Committee’s hearing on the nomination of Rep. Tom Price to head HHS, as well as President Donald Trump’s recent executive order on the health law.

Timeline: The Orphan Drug Act

KFF Health News Original

Follow the twists and turns of the orphan drug industry over the past three decades.

Interactive: How Orphan Drugs Win The ‘Monopoly’ Game

KFF Health News Original

Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.

Video Highlights: Trump Vows Replacement Will Pass At Same Time As Health Repeal

KFF Health News Original

President-elect Donald Trump says his administration will offer its plan to overhaul the federal health law once Rep. Tom Price is confirmed as the secretary of the Department of Health and Human Services.

A Peer Recovery Coach Walks The Frontlines Of The Opioid Epidemic

KFF Health News Original

Charlie Oen was addicted to heroin as a teenager. At 25, he’s now clean and a peer counselor in Lima, Ohio, where he tries to help people who started using drugs before he was born.

Podcast: The GOP’s Path To ‘Repeal And Replace’ May Not Be So Easy

KFF Health News Original

KHN’s Julie Rovner and Mary Agnes Carey, The New York Times’ Margot Sanger-Katz and The Lancet’s Richard Lane discuss the future of the Affordable Care Act under GOP control of both the White House and Capitol Hill.

The Health Law: Rising Costs, Subsidies And Its Future Under The Next President

KFF Health News Original

Affordable Care Act premiums will increase by an average of 25 percent next year, according to new reports. But more than 8 in 10 consumers could be cushioned from the price hikes through subsidies.